Typically, during a 24-hour day, people have periods of sleep and periods of wakefulness but for people living with narcolepsy, periods of sleep are not consolidated – meaning they experience excessive sleepiness during the day and often have trouble sleeping at night – which results in them missing out on continuous, restorative sleep that often makes one feel refreshed.

A disrupted sleep cycle can mean a disrupted life. During the day, excessive daytime sleepiness can mean missing out on work, school, and time with family and friends. Because this condition is misunderstood, or mistaken for other conditions, those with narcolepsy often also experience delays in receiving a proper diagnosis and treatment.

For those who have been diagnosed, fortunately there are treatments available to help manage symptoms of excessive daytime sleepiness and cataplexy – two hallmark and disruptive symptoms of narcolepsy. People can also take an active role in managing their sleep-wake cycle by tracking their sleep patterns to help give them and their doctor a better picture of their days and nights to help spot trends and make changes accordingly.

Dr. Asim Roy, M.D. will help bring awareness to the impact of narcolepsy and offer insights on treatment options. He is joined by Katie who has narcolepsy and will share her experience with the condition and how it’s affected her life.

Interview is courtesy: Avadel Pharmaceutical

#narcolepsy #sleep

The post Wake Up to The Disrupter Affecting Thousands of Americans: NARCOLEPSY, The Condition That Affects Sleep Cycles, World Narcolepsy Day is September 22 appeared first on Good News!.

NEW RESEARCH FROM PROMINENT CANCER MEETING FOR THOSE WITH LUNG CANCER

People with Lung Cancer, Like Others with Serious Underlying Medical Conditions
Might Be at an Increased Risk for Severe Illness from COVID-19

Lung cancer is the second most common cancer in both men and women. This year, an estimated 228,820 adults (116,300 men and 112,520 women) in the United States will be diagnosed.

The fight against lung cancer continues with new research and scientific advances, including cancer experts investigating potential ways to treat the disease in earlier stages. Some of these latest findings in non-small cell lung cancer (NSCLC), including investigational studies in earlier stages of the disease, were presented at the American Society of Clinical Oncology ASCO20 Virtual Scientific Program.

Roy S. Herbst, MD, PhD of Yale Cancer Center and Smilow Cancer Hospital talks on the latest news from ASCO in the fight against lung cancer.

Lung cancer makes up almost 25% of all cancer deaths. There are two main types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC is the most common type of lung cancer. In fact, about 80%-85% of lung cancer cases are NSCLC. About 40% of patients are diagnosed at a later stage of disease, such as Stage IV, when the cancer has progressed to other organs. Approximately 10-15% of NSCLC patients in the US and Europe, and 30-40% of patients in Asia have EGFRm NSCLC. The prevalence of EGFR mutations in early stage are estimated to be ~33% in a global NSCLC population.

Interview courtesy: AstraZeneca
#roy #harbst #yale #cancer #center #smilow #covid-19 #covid #19 #covid19 #lung #severe #illness #medical #risk #diagnosed #research #scientific #advances #disease #cell #nsclc #american #society #clinical #oncology #asco #virtual #hospital #astrazeneca

The post NEW RESEARCH FOR LUNG CANCER appeared first on Good News!.

The post Les (Leslie) Wolff, part 1 + 2 + 3 + 4 appeared first on Good News!.